Octreotide

  • Traffic Light
    Amber (SCG)
  • BNF
    8.3.4.3
  • Licensed Indicators
    Acromegaly, carcinoid tumours/syndrome. If recommended by the palliative care team. Relief of symptoms from neuroendcrine tumours. Including long-acting formulations.
  • Reference
  • Criteria
  • Provisional
    No

Do you want to add this to your CPD record?

Did you find this page helpful?